RobecoSam USA’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$6.91M Sell
43,414
-11,721
-21% -$1.81M 8.22% 2
2016
Q2
$8.15M Buy
55,135
+9,886
+22% +$1.46M 10.14% 1
2016
Q1
$6.41M Sell
45,249
-1,278
-3% -$171K 8.29% 2
2015
Q4
$6.6M Sell
46,527
-3,080
-6% -$411K 8.48% 1
2015
Q3
$6.07M Sell
49,607
-492
-1% -$64.1K 8.75% 2
2015
Q2
$6.5M Sell
50,099
-312
-0.6% -$40.7K 7.53% 3
2015
Q1
$6.77M Buy
50,411
+4,664
+10% +$601K 7.62% 2
2014
Q4
$5.73M Sell
45,747
-20,318
-31% -$2.47M 6.18% 2
2014
Q3
$8.04M Buy
66,065
+17,832
+37% +$2.17M 8.85% 1
2014
Q2
$5.69M Buy
48,233
+10,737
+29% +$1.26M 6.2% 3
2014
Q1
$4.51M Sell
37,496
-16,128
-30% -$1.92M 5.12% 5
2013
Q4
$5.97M Sell
53,624
-8,526
-14% -$848K 6.45% 3
2013
Q3
$5.73M Sell
62,150
-16,658
-21% -$1.51M 7.34% 2
2013
Q2
$6.67M Buy
+78,808
New +$6.56M 9.41% 2

Other funds holding TMO

RobecoSam USA's TMO Position: Q3 2016 in Review

RobecoSam USA reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q3 2016, selling an estimated $1.81M and leaving 43,414 shares worth $6.91M. The position accounts for 8.22% of the portfolio, ranked #2.

RobecoSam USA first reported a position in TMO in Q2 2013 and has held it in 14 quarters since. The position peaked at $8.15M in Q2 2016. 1,045 funds tracked by Wall St. Rank hold TMO as of Q3 2016.

  • RobecoSam USA held 43,414 shares of Thermo Fisher Scientific worth $6.91M as of Q3 2016.
  • RobecoSam USA sold 11,721 Thermo Fisher Scientific shares in Q3 2016, an estimated $1.81M.
  • Thermo Fisher Scientific made up 8.22% of RobecoSam USA's portfolio in Q3 2016, its #2 holding.
  • RobecoSam USA first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 14 quarters since.
  • RobecoSam USA's Thermo Fisher Scientific position peaked at $8.15M in Q2 2016.
  • 1,045 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2016.

Based on RobecoSam USA's 13F filing for Q3 2016, filed 9 Nov 2016.